Practical Considerations for Markush Claims

Markush claim structure

A Markush claim recites alternatives that may occupy a claimed position or perform a claimed function. The format is common in chemistry, pharmaceuticals, biotechnology, and materials science, but it can also be used for mechanical elements and process steps. The term derives from Ex parte Markush, a 1924 U.S. Patent Office decision.

A conventional formulation is “selected from the group consisting of A, B, and C.” In U.S. practice, “consisting of” creates a closed list for that claim element. Alternatives outside the listed group are ordinarily excluded from that element, even if the claim uses “comprising” as the transition for the claim as a whole. The interaction between the claim transition and the Markush phrase must therefore be reviewed separately.

Examples

1. Compound claim: “A compound of Formula 1, wherein R¹ is selected from the group consisting of hydrogen, methyl, ethyl, and propyl.”
2. Pharmaceutical composition claim: “A pharmaceutical composition comprising compound A and a pharmaceutically acceptable carrier selected from the group consisting of lactose, mannitol, starch, and microcrystalline cellulose.”
3. Process claim: “A process for preparing compound Y by reacting compound X with a base in a solvent, wherein the base is selected from the group consisting of sodium hydroxide, potassium hydroxide, sodium carbonate, and potassium carbonate.”

These forms can cover several alternatives in one claim, but the claim remains subject to the ordinary requirements for clarity, written description, enablement, novelty, and inventive step or non-obviousness.

U.S. grouping requirements

Under USPTO MPEP § 2117, a Markush grouping is proper when its members share a single structural similarity and a common use. Members of a recognized physical, chemical, or art-recognized class may satisfy this standard when they are functionally equivalent in the claimed context. Chemical alternatives outside a recognized class may still form a proper group if they share a substantial structural feature that is essential to their common use.

The analysis concerns the claimed alternatives as complete embodiments, not isolated substituents viewed without the rest of the claimed structure. A group may be rejected as improper if the alternatives do not share the required structural relationship or common use. The applicant may respond by showing that the relationship exists or by separating the alternatives into independent or dependent claims.

Clarity, written support, and enablement

A large list of alternatives does not by itself establish lack of clarity or enablement. The specification must nevertheless support the claimed genus and enable a skilled person to practice its scope without undue experimentation. Drafting should address:

• the structural relationship among the alternatives;
• the function or technical effect shared by the alternatives;
• representative species across the claimed breadth;
• working examples and test data appropriate to the predictability of the field;
• selection criteria for substituents, ranges, and combinations; and
• definitions that make the boundaries of nested Markush groups ascertainable.

Overlapping definitions, inconsistent nomenclature, and multiple nested lists can make the claim boundary difficult to determine. Each alternative should have a clear antecedent basis and a consistent relationship to the formula, composition, or process in which it appears.

Unity of invention

PCT Rule 13 requires one invention or a group of inventions linked by a single general inventive concept. Under Rule 13.2, the claimed inventions must have a technical relationship involving the same or corresponding special technical features. Rule 13.3 applies the same analysis whether the alternatives appear in separate claims or within one claim.

For chemical Markush alternatives, international search practice examines whether the alternatives share a common property or activity and either a significant common structural element or membership in a recognized class relevant to the invention. If the common concept is not established, the searching authority may identify lack of unity and require additional search fees. National offices may apply their own standards after national phase entry.

Prior-art search and claim scope

Every alternative within a Markush group contributes to the search burden. A prior-art disclosure of one species may anticipate the claim if that species falls within the claim, while the effect on remaining subject matter depends on the applicable amendment rules and patentability analysis. Before filing, the search should cover the shared scaffold or function, representative species, known substituent classes, and commercially significant fallbacks.

The expression “consisting of” also affects infringement analysis. In U.S. practice, it creates a strong presumption that the Markush element excludes unlisted alternatives. Broader or different formulations, including “comprising” or “consisting essentially of,” have different legal effects and should be used only when the intended boundary is supported by the specification.

Benefits and limitations

Benefits

• Several structurally or functionally related alternatives can be covered in one claim.
• The format can reduce repetitive claim drafting and claim-count pressure.
• Properly supported alternatives can make simple substitution less effective as a design-around.

Limitations

• An overbroad or heterogeneous group may face grouping, unity, clarity, written-description, or enablement objections.
• A large genus increases the scope and cost of prior-art searching.
• Closed-group wording may exclude a commercially relevant alternative that was not listed.
• Election, restriction, lack-of-unity, and amendment practice differs among jurisdictions.

Common applications

• Chemistry and pharmaceuticals: substituents on a common scaffold, salts, carriers, solvents, catalysts, and reagents.
• Biotechnology: amino-acid or nucleotide alternatives at specified positions, binding domains, vectors, hosts, and assay reagents.
• Materials science: reinforcing agents, metals, ceramics, polymers, fillers, and functional nanoparticle components.
• Processes and devices: alternative process steps, operating units, sensors, or other elements that perform a common claimed function.

Jurisdiction-specific review

The USPTO addresses Markush claims in MPEP § 2117 and related sections on claim interpretation, indefiniteness, and restriction. The EPO Guidelines F‑V, 3.2.5 address unity for chemical and non-chemical Markush alternatives. KIPO examines these claims under the applicable requirements for support, clarity, unity, and patentability. Other offices, including CNIPA, apply their own rules to amendment and post-grant proceedings.

A claim intended for several jurisdictions should be drafted with fallback positions that can survive different search, unity, and amendment rules. The specification should disclose narrower groups, preferred subgroups, individual species, and combinations that may be needed during prosecution or a validity challenge.

Drafting checklist

1. Define the common structure, property, function, or technical effect.
2. Confirm that every listed alternative is supported and enabled.
3. Use closed or open language deliberately and consistently.
4. Include representative examples across the claimed breadth.
5. Search the shared concept and commercially important species.
6. Prepare dependent claims and specification support for narrower groups.
7. Review unity, election, restriction, and amendment practice for each filing jurisdiction.

Markush drafting requires a balance between genus breadth and the disclosure available to support it. That balance should be established before filing because many jurisdictions restrict the introduction of narrower combinations that were not disclosed in the application as filed.